Jump to content

Choose locationCalifornia Pacific Medical Center
  • Sign in or Register
    • I want to choose my medical group or hospital
    • Clear my location
X Close Window

We've expanded your view

You are now viewing all services in the Sutter Health network. You can change your location above to narrow your view to a medical group, hospital, city or zip.
Sutter Health
  • Find Doctors
  • Find Locations
  • Treatments & Services
  • Locations
  • Sign in or Register
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Diseases & Conditions
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Ways to Give
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • CPMC
  • Research
  • Cerebrovascular Disorders
Content

Dabigatran versus warfarin for atrial fibrillation in real-world clinical practice: a systematic review and meta-analysis.

Description

Romanelli RJ, Nolting L, Dolginsky M, Kym E, Orrico KB., Circ Cardiovasc Qual Outcomes. pii: CIRCOUTCOMES.115.002369. [Epub ahead of print], 2016 Jan 26

Investigators

Robert Romanelli, Ph.D., MPH, Associate Scientist

Abstract

BACKGROUND: Trial data for the benefits and risks of dabigatran versus warfarin in the treatment of nonvalvular atrial fibrillation are lacking. We sought to review real-world observational evidence for the comparative effectiveness and safety of these agents.

METHODS AND RESULTS: A systematic search of multiple databases was conducted from first available date to March 10, 2015 for longitudinal, observational studies comparing dabigatran with warfarin. Two reviewers evaluated studies for eligibility and extracted hazard ratios for ischemic stroke and gastrointestinal and intracranial bleeding. hazard ratios were pooled using random-effects meta-analysis. Metaregression was performed to assess treatment-effect heterogeneity. We identified 232 unique citations. Seven retrospective cohort studies met study eligibility criteria, with 348 750 patients and a mean follow-up of 2.2 years. In pooled analyses, dabigatran-150 mg was not superior to warfarin in preventing stroke (hazard ratio, 0.92; 95% confidence interval, 0.84-1.01; P=0.066), but had a significantly lower hazard of intracranial bleeding (0.44; 0.34-0.59; P<0.001). Dabigatran-150 mg had a significantly greater hazard of gastrointestinal bleeding than warfarin (1.23; 1.01-1.50; P=0.041), which was potentiated in studies of older (elderly) versus younger populations (median/mean age, ≥75 versus <75 years; β=1.53; 95% confidence interval, 1.10-2.14; P=0.020).

CONCLUSIONS: In real-world clinical practice, dabigatran is comparable with warfarin in preventing ischemic stroke among patients with nonvalvular atrial fibrillation. However, dabigatran is associated with a lower risk for intracranial bleeding relative to warfarin, but, particularly among the elderly, a greater risk for gastrointestinal bleeding. Bleeding outcomes from observational studies are consistent with those from the pivotal Randomized Evaluation of Long-Term Anticoagulation Therapy trial.

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

  • Aging and Longevity
  • Cerebrovascular Disorders
  • Disease Management
  • Medical Informatics

Related Publications

Perceived appropriateness of shared decision-making in the emergency department: a survey study.

Probst MA, Kanzaria HK, Frosch DL, Hess EP, Winkel G, Ngai KM, Richardson LD.
Acad Emerg Med. 23(4):375-81. doi: 10.1111/acem.12904. Epub 2016 Mar 22.
2016 Apr 01

Intracardiac papillary fibroelastoma: an occult cause of embolic neurologic deficit.

McFadden PM, Lacy JR.
Ann Thorac Surg. 43(6):667-9.
1987 Jun 01

Geographic variations in cardiovascular disease mortality among Asian American subgroups, 2003-2011.

Pu J, Hastings KG, Boothroyd D, Jose PO, Chung S, Shah JB, Cullen MR, Palaniappan LP, Rehkopf DH.
J Am Heart Assoc. 6(7). pii: e005597. doi: 10.1161/JAHA.117.005597.
2017 Jul 12

Complete visual recovery after incipient CRAO due to ocular hypoperfusion in a patient with moyamoya disease.

Lad EM, Lad SP, Ung C, Jain A, Steinberg GK, Gaynon MW.
Retin Cases Brief Rep. 7(3):248-51. doi: 10.1097/ICB.0b013e31828eef20.
2013 Jul 01

Dyslipidemia in special ethnic populations.

Pu J, Romanelli R, Zhao B, Azar KM, Hastings KG, Nimbal V, Fortmann SP, Palaniappan LP.
Cardiol Clin. 33(2):325-333. doi: 10.1016/j.ccl.2015.01.005.
2015 May 01
The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

About Sutter

  • About Our Network
  • Annual Report
  • Awards
  • Community Benefit
  • Contact Us
  • News Room
  • Ways to Give
  • Find Care

  • Birth Centers
  • Care Centers
  • Emergency Rooms
  • Hospitals
  • Imaging
  • Labs
  • Surgery Centers
  • Urgent Care
  • Walk-In Care
  • View All >
  • Featured Services

  • Behavioral Health
  • Cancer Services
  • Family Medicine
  • Home Health and Hospice
  • Orthopedics
  • Pediatrics
  • Pregnancy
  • Primary Care
  • Women's Health
  • View All >
  • Patient Resources

  • Accepted Health Plans
  • Classes and Events
  • Estimate Costs
  • Flu Resources
  • Health and Wellness
  • Medical Records
  • Medicare
  • My Health Online
  • Pay a Bill
  • Symptom Checker
  • Our Team

  • For Employees
  • Physician Careers
  • Recruiting Events
  • Sutter Careers
  • Vendors
  • Volunteers
    • ADA Accessibility
    • Contact
    • Privacy Policy
    • Terms of Use

    • LinkedIn Opens new window
    • YouTube Opens new window
    • Facebook Opens new window
    • Twitter Opens new window
    • Glassdoor Opens new window
    • Instagram Opens new window

    Copyright © 2019 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.